Cuban President Miguel Diaz-Canel Bermudez and his Iranian counterpart Ayatollah Seyed Ebrahim Raisi visited the Center for Genetic Engineering and Biotechnology (CIGB). Author: Revolutionary Research
The history of cooperation in the field of healthcare and the biotechnology industry has developed over the past decades between the Republic of Cuba and the Islamic Republic of Iran, based on long-standing and strong ties.
The visit of Cuban President Miguel Diaz-Canel Bermudez and Iranian President Ayatollah Seyyed Ebrahim Raisi to the Center for Genetic Engineering and Biotechnology (CIGB) this Thursday confirmed how much progress has been made in these areas and how much more can be done to benefit the health of both peoples.
During a working day at a prestigious Cuban institution, where the head of state was accompanied by Foreign Minister Bruno Rodríguez Parrilla and Health Minister José Angel Portal Miranda, the Iranian delegation received a detailed explanation of the potential for
promote exchange between the two countries, especially in the field of medicine and vaccine production, as well as the transfer of technology for this.
In this sense, BioCubaFarma Vice President Maida Mauri spoke about the wide range of innovative products developed by this business group, currently composed of 46 companies and more than 19,000 employees. I want to reaffirm, he said, “the desire to continue to develop strategic relationships with our Iranian brothers in this sector of biotechnology and the pharmaceutical industry.”
These research collaboration links, which have their origins in an important milestone, which is the collaboration established between Iran’s Pasteur Institute and the Finley Institute for Vaccines (IFV) to collaborate on a Cuban pneumococcal vaccine, was also mentioned by Dr. Vicente Veres Bencomo, General director of this institution.
This relationship of transfer and co-development was the starting point for achieving, in difficult moments of confrontation with the COVID-19 pandemic, Veres Bencomo argued, the only agreement signed by Cuba on the transfer of Cuban SARS-CoV-2 vaccine technology. . We signed it, he assured, in addition to “the brotherhood of our peoples, for what we put forward in the original draft.”
Finally, both delegations moved to the complex
CIGB factories, where they could see in real time the production of active ingredients, vaccines and drugs, the production and development processes of which were explained by the director of this center, Marta Ayala Avila.
Source: Juventud Rebelde